Julian Gold

5.4k total citations
100 papers, 3.6k citations indexed

About

Julian Gold is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Julian Gold has authored 100 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 32 papers in Epidemiology and 14 papers in Virology. Recurrent topics in Julian Gold's work include HIV/AIDS Research and Interventions (31 papers), HIV, Drug Use, Sexual Risk (22 papers) and HIV Research and Treatment (14 papers). Julian Gold is often cited by papers focused on HIV/AIDS Research and Interventions (31 papers), HIV, Drug Use, Sexual Risk (22 papers) and HIV Research and Treatment (14 papers). Julian Gold collaborates with scholars based in Australia, United States and United Kingdom. Julian Gold's co-authors include D. A. Cooper, Robert Finlayson, Gavin Giovannoni, Ronald Penny, Basil Donovan, Alex Wodak, Michael W. Ross, Arthur D. Boyd, S. Justin Thomas and David A. Cooper and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Julian Gold

95 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julian Gold Australia 32 1.4k 1.0k 871 401 360 100 3.6k
Julie Fox United Kingdom 32 1.4k 1.0× 792 0.8× 975 1.1× 559 1.4× 340 0.9× 181 3.4k
Stanley Read Canada 37 1.5k 1.0× 1.1k 1.1× 749 0.9× 453 1.1× 110 0.3× 142 3.4k
Harry Hollander United States 40 1.4k 1.0× 1.6k 1.6× 965 1.1× 267 0.7× 290 0.8× 89 4.6k
David L. Hom United States 30 1.4k 1.0× 1.1k 1.0× 508 0.6× 308 0.8× 494 1.4× 50 2.9k
Philip Rhodes United States 30 1.5k 1.1× 1.6k 1.5× 462 0.5× 483 1.2× 187 0.5× 55 3.9k
Tim Spelman Australia 40 1.3k 0.9× 1.4k 1.4× 459 0.5× 514 1.3× 682 1.9× 222 4.7k
Brian K. Agan United States 36 2.2k 1.6× 1.6k 1.6× 1.7k 1.9× 485 1.2× 281 0.8× 167 4.6k
Samantha MaWhinney United States 37 1.5k 1.1× 925 0.9× 1.4k 1.7× 869 2.2× 339 0.9× 143 4.6k
Jill Ward United States 6 2.1k 1.5× 1.6k 1.6× 1.3k 1.5× 270 0.7× 324 0.9× 11 3.9k
H. W. Jaffe United States 9 2.2k 1.6× 1.8k 1.7× 1.5k 1.7× 357 0.9× 275 0.8× 9 4.2k

Countries citing papers authored by Julian Gold

Since Specialization
Citations

This map shows the geographic impact of Julian Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julian Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julian Gold more than expected).

Fields of papers citing papers by Julian Gold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julian Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julian Gold. The network helps show where Julian Gold may publish in the future.

Co-authorship network of co-authors of Julian Gold

This figure shows the co-authorship network connecting the top 25 collaborators of Julian Gold. A scholar is included among the top collaborators of Julian Gold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julian Gold. Julian Gold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giovannoni, Gavin, Louisa K. James, Julian Gold, et al.. (2025). The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis. Brain. 148(9). 3057–3071. 2 indexed citations
2.
Liu, Xinhao, et al.. (2025). DeST-OT: Alignment of spatiotemporal transcriptomics data. Cell Systems. 16(2). 101160–101160. 4 indexed citations
3.
Gold, Julian, et al.. (2024). A count-based model for delineating cell–cell interactions in spatial transcriptomics data. Bioinformatics. 40(Supplement_1). i481–i489. 1 indexed citations
4.
Damron, Michael, et al.. (2023). On the number and size of holes in the growing ball of first-passage percolation. Transactions of the American Mathematical Society. 377(3). 1641–1670. 1 indexed citations
5.
Dobson, Ruth, David W. Holden, Nicola Vickaryous, et al.. (2023). A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis. Multiple Sclerosis Journal. 30(1). 63–70. 1 indexed citations
6.
Phan, Katherine, Ying He, YuHong Fu, et al.. (2021). Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia. SHILAP Revista de lepidopterología. 1(1). 22 indexed citations
7.
Giovannoni, Gavin, Chris Hawkes, Jeannette Lechner‐Scott, et al.. (2020). The COVID-19 pandemic and the use of MS disease-modifying therapies. Multiple Sclerosis and Related Disorders. 39. 102073–102073. 131 indexed citations
8.
Holden, David W., Julian Gold, Christopher H. Hawkes, et al.. (2018). Epstein Barr virus shedding in multiple sclerosis: Similar frequencies of EBV in saliva across separate patient cohorts. Multiple Sclerosis and Related Disorders. 25. 197–199. 13 indexed citations
9.
Gold, Julian, Mónica Marta, Ute‐Christiane Meier, et al.. (2018). A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study. Multiple Sclerosis and Related Disorders. 24. 123–128. 26 indexed citations
10.
11.
Gold, Julian, et al.. (2014). HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study. Journal of Neurology Neurosurgery & Psychiatry. 86(1). 9–12. 72 indexed citations
12.
Over, Mead, Ana Revenga, Wiwat Peerapatanapokin, et al.. (2007). The economics of effective AIDS treatment in Thailand. AIDS. 21(Suppl 4). S105–S116. 34 indexed citations
13.
Graepel, Thore, Ralf Herbrich, & Julian Gold. (2004). LEARNING TO FIGHT. 193–200. 51 indexed citations
14.
Over, Mead, Peter Heywood, Julian Gold, et al.. (2004). HIV/AIDS Treatment and Prevention in India : Modeling the Cost and Consequences. World Bank Publications. 2 indexed citations
15.
Agnew, Linda L., Mark Kelly, Jonathan Howard, et al.. (2003). Altered lymphocyte heat shock protein 70 expression in patients with HIV disease. AIDS. 17(13). 1985–1988. 17 indexed citations
16.
Ross, Michael W., et al.. (1995). Reliability of Interview Responses of Injecting Drug Users. Journal of Addictive Diseases. 14(2). 1–12. 9 indexed citations
17.
Oliver, Christopher J., et al.. (1993). Total Body Protein Status of Males Infected with the Human Immunodeficiency Virus. PubMed. 60. 197–200. 3 indexed citations
18.
Gold, Julian, et al.. (1990). HIV‐related risk‐taking behaviour, knowledge and serostatus of intravenous drug users in Sydney. The Medical Journal of Australia. 152(9). 453–458. 36 indexed citations
19.
Binkin, Nancy, Julian Gold, & Willard Cates. (1982). Illegal-Abortion Deaths in the United States: Why Are They Still Occurring?. Family Planning Perspectives. 14(3). 163–163. 11 indexed citations
20.
Gold, Julian. (1980). Herbal Abortifacients. JAMA. 243(13). 1365–1365. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Fox Breakdown of academic impact, for papers by Stanley Read Breakdown of academic impact, for papers by Harry Hollander Breakdown of academic impact, for papers by David L. Hom Breakdown of academic impact, for papers by Philip Rhodes Breakdown of academic impact, for papers by Tim Spelman Breakdown of academic impact, for papers by Brian K. Agan Breakdown of academic impact, for papers by Samantha MaWhinney Breakdown of academic impact, for papers by Jill Ward Breakdown of academic impact, for papers by H. W. Jaffe
Rankless by CCL
2026